EUCTR2013-000992-33-DE进行中（未招募）1 期
A Clinical Study to Assess the Efficacy and Onset of Pain Relief of Topical MFC51123 Diclofenac-Menthol Gel versus Controls in Ankle Sprain
GlaxoSmithKline Consumer Healthcare0 个研究点开始时间: 2013年6月24日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Consent: Subject demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
- •2. Age: Subject is from 16 to 65 years of age.
- •3. Compliance: Subject understands and is willing, able and likely to comply with all study procedures and restrictions.
- •4. General Health: Subject is in good general and mental health with, in the opinion of the investigator or medically qualified designee:
- •a) No clinically significant and relevant abnormalities of medical history or physical examination.
- •b) No condition that would impact on the subject’s safety or wellbeing or affect his or her ability to understand and follow study procedures and requirements.
- •5. Diagnosis:
- •a) Subject has a Grade I or Grade II acute sprain of the lateral ankle within 24 hours of Visit 1
- •b) Subject has self-assessed pain intensity at the site of the ankle sprain that is = 5 as measured on an 11-point numerical rating scale
- •c) Subject has a peri-malleolar edema (sub-malleolar perimeter difference of = 20mm between injured and uninjured ankle
- •6. Contraception: Females of childbearing potential who are, in the opinion of the investigator, practicing a reliable method of contraception. For the purposes of this study, reliable contraception is defined as abstinence, oral contraceptive, either combined or progestogen alone OR injectable progestogen OR implants of
- •levonorgestrel OR estrogenic vaginal ring OR percutaneous contraceptive patches OR intrauterine device or intrauterine system OR double barrier method (condom or occlusive cap [diaphragm or cervical vault caps] plus
- •spermicidal agent [foam, gel, film, cream, suppository]) OR male partner sterilization prior to the female subject's entry into the study, and this male is the sole partner for that subject.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 40
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 360
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Pregnancy: Women who are pregnant or who have a positive urine pregnancy test.
- •2. Breast-feeding: Women who are breast–feeding.
- •3. Subject has treated the ankle sprain with treatment such as oral or other topical pain relief medications, massage or physical therapy since experiencing the ankle sprain. The application of ice to the affected ankle
- •prior to visit 1 is allowed.
- •4. Subject has other acute or chronic pain disorders, which may confound the study pain evaluations.
- •5. Subject suffered from a grade I-III ankle sprain at the same ankle or any other significant injuries (based on investigator’s judgment), or surgeries at the same ankle or foot within 30 days from the current injury. Pain and instability exist at the same ankle due to previous sprain or other trauma. Ligament hyperlaxity occuring at the same ankle due to connective tissue diseases, e.g. Marfan’s syndrome, Down’s syndrome, Ehlers-Danlos Syndrome, etc.
- •6. Subject has injury to both ankles or to both medial and lateral ligaments of the same ankle.
- •7. Allergy/Intolerance: Subject has known or suspected hypersensitivity, allergy, intolerance or contraindication to the use of any of the study medications (or closely related compounds), any of their stated ingredients or any topical medications before.
- •8. Subject is currently taking or has taken within the previous three months medications or herbal supplements likely, on available evidence, to interfere with the validity of subject-rated assessments.
- •9. Subject has a medical history of renal or hepatic disease, a current active peptic ulcer or a history of upper gastrointestinal bleeding or perforation related to previous NSAID therapy.
- •10. Clinical Study/Experimental Medication:
- •a) Subject has participated in another clinical study or received an investigational drug within 30 days of Visit 1.
- •b) Subject has previously participated in this study.
- •11. Substance abuse: Subject has a recent history (within the last 2 years) of alcohol or other substance abuse.
- •12. Personnel: Subject is an employee of the sponsor or the study site or members of their immediate family.
研究者
相似试验
尚未招募
不适用
A clinical study for evaluating the efficacy and safety of long-term consumption of the honey vinegar beverage on lowering blood pressure in the subjects with high normal blood pressure or grade 1 hypertensiohypertensionJPRN-UMIN000016456Soiken Inc.100
已完成
2 期
Clinical study to investigate the efficacy and the safety of R-FM for recurrent or refractory indolent B-cell lymphoma - THF016JPRN-UMIN000005442Tohoku Hematology Forum40
招募中
Unknown
A clinical study to evaluate the effectiveness and safety of HJHP on cognitive function improvementKCT0008744Ewha Womens University80
招募中
2 期
A Study to Evaluate the Efficacy and Safety of Coolief Cooling Radiofrequency Therapy for Chronic Pain after Total Knee Arthroplasty.Prolonged Post-surgical PainTotal Knee Arthroplasty, Prolonged Chronic PainD010149JPRN-jRCTs052230123Matsumoto Tomoyuki6
已完成
2 期
A study to determine the efficacy and safety of using remimazolam for dental procedures under sedation.JPRN-jRCTs061220052Kana Oue30